About N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide
N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide (PubChem CID 97070585) has the molecular formula C17H31N3O2
and a molecular weight of 309.45 g/mol. Its IUPAC name is N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide.
Analyze N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide?
The IUPAC name of N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide (CID 97070585) is N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide.
What is the SMILES notation for N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide?
The canonical SMILES for N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide is C[C@H]1OCC[C@H]1NC1CCN(C(=O)NC2CCCCC2)CC1.
What is the InChIKey of N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide?
The InChIKey is CGZIWXVYKDPYOV-CZUORRHYSA-N. The full InChI is InChI=1S/C17H31N3O2/c1-13-16(9-12-22-13)18-15-7-10-20(11-8-15)17(21)19-14-5-3-2-4-6-14/h13-16,18H,2-12H2,1H3,(H,19,21)/t13-,16-/m1/s1.
What are the key properties of N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide?
N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide has a molecular weight of 309.45 g/mol, XLogP of 2.26, 3 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-4-[[(2R,3R)-2-methyloxolan-3-yl]amino]piperidine-1-carboxamide is sourced from PubChem (CID 97070585), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).